The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill

Guoqing Zhou

Status: Completed

Conditions: Climacteric Syndrome

Treatments: Drug: Luo-Bu-Fu-Ke-Bi-RI Pill; Drug: tibolone

Study type: Observational

Funder types: Other

Identifiers

NCT05846698

2021-375

Details and patient eligibility

About

To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.

Enrollment: 276 patients

Sex: Female

Ages: 41 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Clinical diagnosis of climacteric syndrome

Trial design

276 participants in 2 patient groups

control group

Treatment:

Drug: tibolone

treatment group

Treatment:

Drug: Luo-Bu-Fu-Ke-Bi-RI Pill